Multiple Myeloma and Lenalidomide
- Lenalidomide is a medication commonly used in the treatment of multiple myeloma.
- It belongs to a class of drugs called immunomodulatory agents and has been shown to have anti-cancer properties.
- Lenalidomide works by inhibiting the growth and proliferation of cancer cells,
- stimulating the immune system and interfering with the microenvironment that supports tumor growth.
- Lenalidomide is often used in combination with other medications, such as
- dexamethasone, for the treatment of multiple myeloma. It may be prescribed for newly diagnosed patients
- who are eligible for stem cell transplantation, as well as for those with relapsed or refractory disease.
- It’s important to note that lenalidomide may have certain side effects, and its use should be closely monitored by healthcare professionals. Common side effects may include fatigue, diarrhea, constipation, skin rash, and lowered blood cell counts